New blood test for newborn infection
Part of Genetic & congenital, Infections clinical trials.
This study is testing a new blood test (called presepsin) to see if it can help doctors quickly diagnose sepsis (a serious infection) in newborns. If your baby has signs of infection, this test might help find the cause sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is less than 1 month old.
- Your baby has signs of a possible infection (like fever, trouble breathing, or feeding problems), or the mother had risk factors for infection during labor.
- Your baby has not already received antibiotics before coming to the hospital.
- Your baby did not have a lack of oxygen at birth (birth asphyxia).
- Your baby does not have a known or suspected metabolic disorder.
- Your baby does not have a major birth defect (like a heart defect).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood markers like lactate and complete blood count (CBC) can help spot infection in newborns up to 28 days old. It may lead to faster, more accurate diagnosis for babies with possible sepsis.
This study tests whether adding N-acetylcysteine (NAC) to standard care helps newborns with sepsis recover better. It is for babies born at 32 weeks or later, within the first 28 days of life, who have a confirmed infection.
This study uses ultrasound to measure how a newborn's heart pumps during serious blood infections (sepsis). Researchers want to understand how sepsis affects heart function in babies, which may help doctors treat newborns better.
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
Hear when a new Neonatal Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.